[Interaction of ouabain and lipolytic drugs].
D000251:Adenosine Triphosphatases / Q000037:antagonists & inhibitors; D000273:Adipose Tissue / Q000187:drug effects*; D000818:Animals; D002395:Catecholamines / Q000494:pharmacology*; D000242:Cyclic AMP / Q000494:pharmacology; D004822:Epididymis / Q000187:drug effects; D004837:Epinephrine / Q000494:pharmacology; D007545:Isoproterenol / Q000494:pharmacology; D007700:Kinetics; D050356:Lipid Metabolism; D008297:Male; D009638:Norepinephrine / Q000494:pharmacology; D010042:Ouabain / Q000037:antagonists & inhibitors / Q000494:pharmacology*; D051381:Rats; D013806:Theophylline / Q000494:pharmacology
D002395:Catecholamines; D010042:Ouabain; D013806:Theophylline; D000242:Cyclic AMP; D000251:Adenosine Triphosphatases; D007545:Isoproterenol; D009638:Norepinephrine; D004837:Epinephrine
Interaction de l'ouabaïn et des drogues lipolytiques.